Senate Majority Leader Chuck Schumer (Graeme Sloan/Sipa USA)(Sipa via AP Images)
Schumer pledges vote on $35 insulin caps next month as other pricing reforms remain on hold for now
If the Senate fails to pass a $35 monthly insulin cap late next month, which it’s expected to do, what would be next for drug pricing reforms on Capitol Hill?
That’s the major question right now as Senate Majority Leader Chuck Schumer (D-NY) said Tuesday that following the Senate recess for the Easter holiday (returning on April 25), he will bring to a vote a bill that would cap monthly insulin costs at $35 for those with insurance, which aligns with President Biden’s pledge for such a cap at the State of the Union.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
